ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 894 • 2015 ACR/ARHP Annual Meeting

    Late-Onset IgA Vasculitis in Adult Patients Exhibits Distinct Clinical Characteristics and Outcomes

    Seokchan Hong1, Soo Min Ahn1, Doo-Ho Lim2, Byeongzu Ghang3, Wook Jang Seo4, Yong-Gil Kim1, Chang-Keun Lee1 and Bin Yoo2, 1Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Department of Rheumatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Univerisy of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 4Internal Medicine, Seoul Veterans Hospital, Seoul, South Korea

    Background/Purpose: To determine whether adult IgA vasculitis patients who developed disease at an older age differ from early-onset patients in terms of clinical features and…
  • Abstract Number: 895 • 2015 ACR/ARHP Annual Meeting

    Relapses and Predictive Factors in Henoch-SchÖnlein Purpura. study of 417 Patients

    Natalia Palmou1, Vanesa Calvo-Río1, Javier Loricera1, Enar Pons2, Patricia Fuentevilla3, Jose L. Hernández4, Cristina Mata-Arnaiz5, L. Martín6, Francisco Ortiz-Sanjuán1, L Alvarez7, Carmen Gonzalez-Vela8, Domingo González-Lamuño9, Hector Fernandez-Llaca10, MA González López11, S. Armesto10, M Arias12, Miguel Angel Gonzalez-Gay1 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 2RHEUMATOLOGY, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, SANTANDER, Spain, 3Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, santander, Spain, 4Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 5Rheumatology, Hospital Laredo, Santander, Spain, 6Nephrology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 7PEDIATRIC, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, SANTANDER, Spain, 8Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 9Pediatrics, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 10Dermatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 11Dermatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, santander, Spain, 12nephrology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, santander, Spain

     Background/Purpose: Although the prognosis of Henoch-Schönlein purpura (HSP) is usually favorable, relapses are relatively frequent.Objectives: Our aim was to analyze the frequency, type and risk…
  • Abstract Number: 896 • 2015 ACR/ARHP Annual Meeting

    Herpes Zoster and the Short Term Risk for Ischemic Stroke in Patients with Autoimmune Diseases

    Leonard H. Calabrese1, Fenglong Xie2, Huifeng Yun3, Kevin L. Winthrop4, John Baddley5, Cassandra Calabrese6 and Jeffrey R. Curtis7, 1Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH, 2Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 3Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 4Oregon Health and Science University, Portland, OR, 5Infectious Diseases, University of Alabama, Birmingham, AL, 6Cleveland Clinic Foundation, Cleveland, OH, 7University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Herpes zoster (HZ) is an opportunistic infection caused by Varicella Zoster Virus (VZV); HZ is observed with increasing frequency in patients on immunosuppressive therapies. HZ is not…
  • Abstract Number: 897 • 2015 ACR/ARHP Annual Meeting

    Intra-Articular Corticosteroids Are Safe and Have No Major Effect on Structural Progression of Synovitic Knee OA: A 2-Year Randomized Controlled Trial of 3-Monthly Triamcinolone Hexacetonide

    Jeffrey Driban1, Michael P. Lavalley2, Lori Lyn Price3, William F. Harvey4 and Timothy E. McAlindon4, 1Tufts Medical Center, Boston, MA, 2Biostatistics, Boston University, Boston, MA, 3Clinical Care Research, Tufts Medical Center, Boston, MA, 4Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Synovitis is common in knees with OA, and is associated with structural progression. Intra-articular corticosteroids are widely used and could reduce knee OA cartilage…
  • Abstract Number: 898 • 2015 ACR/ARHP Annual Meeting

    A Randomized Double-Blind Study of Denosumab Compared with Zoledronic Acid in Postmenopausal Women with Osteoporosis Previously Treated with Oral Bisphosphonate

    PD Miller1, N Pannacciulli2, JP Brown3, E Czerwinski4, BS Nedergaard5, MA Bolognese6, J Malouf7, HG Bone8, JY Reginster9, A Singer10, C Wang2, RB Wagman2 and SR Cummings11, 1Colorado Center for Bone Research, Lakewood, CO, 2Amgen Inc., Thousand Oaks, CA, 3Laval University and CHU de Québec (CHUL) Research Centre, Québec City, QC, Canada, 4Krakow Medical Center, Krakow, Poland, 5Center for Clinical and Basic Research, Aalborg, Denmark, 6The Bethesda Health Research Center, Bethesda, MD, 7Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 8Michigan Bone and Mineral Clinic, Detroit, MI, 9University of Liège, Liège, Belgium, 10Georgetown University Medical Center, Washington, DC, 11San Francisco Coordinating Center, CPMC Research Institute, San Francisco, CA

    Background/Purpose: Oral bisphosphonates are the most common osteoporosis treatment, but inconvenient dosing regimens and side effects lead to low adherence. Less frequently dosed bisphosphonates, eg,…
  • Abstract Number: 899 • 2015 ACR/ARHP Annual Meeting

    HA20: A Novel Autoinflammatory Disease Caused By Haploinsufficiency of A20, Encoded By TNFAIP3  

    Qing Zhou1, Hongying Wang2, Daniella M. Schwartz3, Monique Stoffels4, Yong Hwan Park2, Yuan Zhang5, Erkan Demirkaya6, Masaki Takeuchi2, Jonathan J. Lyons5, Xiaomin Yu5, Claudia Ouyang7, Amanda K. Ombrello2, Deborah L. Stone2, Patrycja Hoffmann2, Anne Jones2, Helen L. Leavis8, Annet van Royen-Kerkhof8, Ahmet Gül9, Seza Ozen10, Richard Siegel11, Massimo Gadina12, JaeJin Chae2, Ronald Laxer13, Daniel L. Kastner2 and Ivona Aksentijevich2, 1Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 2National Human Genome Research Institute, Bethesda, MD, 3Rheumatology fellowship and training branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 5National Institute of Allergy and Infectious Diseases, Bethesda, MD, 6Pediatric Rheumatology, Gulhane Military Medical Academy, FMF Arthritis Vasculitis and Orphan disease Research Center (FAVOR),, Ankara, Turkey, 7National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 8University Medical Center Utrecht, Utrecht, Netherlands, 9Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 10Pediatric Nephrology and Rheumatology, Hacettepe University, Ankara, Turkey, Ankara, Turkey, 11National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 12NIAMS/NIH, Bethesda, MD, 13The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: We describe a new autoinflammatory syndrome caused by high penetrance heterozygous germline mutations in the NFκB regulatory protein TNFAIP3 (A20) in six unrelated families…
  • Abstract Number: 900 • 2015 ACR/ARHP Annual Meeting

    A Multidimensional  Immunomics Approach Annotates an Immunome Shaped By the Interplay Between the Periphery and the Skin Microenvironment in Systemic Sclerosis

    Hari Balaji Venkatanarayanan1,2, Andrea Low3, Raymond Ong Jr.4, Liyun Lai1,2, Juntao Li2,5, Chie Hwee Ang1,2, Suzan Saidin1,2, Camillus Chua1,2, Jing Yao Leong1,2, Agnieszka Maliszewska1,2, Lakshmi Ramakrishna1,2, Julian Thumboo6 and Salvatore Albani1,2, 1SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 2Duke-National University of Singapore Graduate Medical School, Singapore, Singapore, 3Division of Rheumatology, Singapore General Hospital, Singapore, Singapore, 4Singhealth Translational Immunology and Inflammation Centre (STIIC), Singapore Health Services Pte Ltd, Singapore, Singapore, 5SingHealth Translational Immunology and Inflammation Centre (STIIC), Singapore Health Services Pte Ltd, Singapore, Singapore, 6Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore

    Background/Purpose: Systemic sclerosis (SSc), is a chronic autoimmune disorder of the connective tissue. There is an unmet need to define precise immune correlates involved in…
  • Abstract Number: 901 • 2015 ACR/ARHP Annual Meeting

    Novel B Cell-Derived Peptide Regulation of Homeostatic T-Cell Trafficking Is Subverted in Rheumatoid Arthritis

    Helen McGettrick1, Myriam Chimen2, Ashley Martin3, Francesca Barone4, Andrew Filer5, Karim Raza6, Christopher Buckley4, Parth Narendran7 and G. Ed Rainger2, 1Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 2Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom, 3School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom, 4University of Birmingham, Rheumatology Research Group, Birmingham, United Kingdom, 5University of Birmingham, Birmingham, United Kingdom, 6University of Birmingham, Rheumatology Research Group, Institute of Inflammation and Ageing, United Kingdom, Birmingham, United Kingdom, 7Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom

    Background/Purpose: In rheumatoid arthritis (RA), inappropriate recruitment of T-cells into the joint contributes to disease pathogenesis and joint destruction. We examined the ability of adiponectin…
  • Abstract Number: 902 • 2015 ACR/ARHP Annual Meeting

    Inhibitor of DNA Binding 1 As a Fibroblast Derived Inflammatory Angiogenic Agonist in Rheumatoid Arthritis

    Gautam Edhayan1, Christine M. Ha1, Ray A. Ohara1, Takeo Isozaki1, M. Asif Amin1, Ali S. Arbab2, Phillip L. Campbell1, Rachel Morgan1, W. Alexander Stinson3, Sean C. Friday1, David A. Fox1 and Jeffrey H. Ruth1, 1Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 2Georgia Regents University, Augusta, GA, 3Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: Inhibitor of DNA binding 1 (Id1) is a nuclear protein containing a basic helix-loop-helix (bHLH) domain that regulates cell growth by selective binding and…
  • Abstract Number: 903 • 2015 ACR/ARHP Annual Meeting

    CGEN-15001, a Novel B7-like Protein, Controls Inflammation in a Translational Rheumatoid Arthritis (RA) Assay and Induces Treg Driven Long-Term Remission in an Autoimmune Disease Model

    Iris Hecht1, Ashley Gilmour2, Clare Tange2, Donna McIntyre2, Joseph R. Podojil3, Kay McNamee4, Galit Rotman5, Eyal Neria5, Mariola Kurowska-Stolarska2, Richard O. Williams4, Stephen D. Miller3 and Iain B. McInnes2,6, 1Therapeutic Proteins, Compugen Ltd., Tel Aviv, Israel, 2Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 3Microbiology-Immunology, Northwestern University, Chicago, IL, 4Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom, 5Compugen Ltd., Tel Aviv, Israel, 6Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: CGEN-15001 is an Fc fusion protein composed of the extracellular domain of a novel B7-like protein. Therapeutic CGEN-15001 treatment is effective in collagen induced…
  • Abstract Number: 904 • 2015 ACR/ARHP Annual Meeting

    Intracerebroventricular Tweak (TNF-like weak inducer of apoptosis) Induces Depressive-like Behavior and Cognitive Dysfunction in Non-Autoimmune Mice

    Jing Wen1, Christopher Chen1, Ariel Stock1, Jessica Doerner1, Maria Gulinello1 and Chaim Putterman1,2, 1Albert Einstein College of Medicine, Bronx, NY, 2Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Neuropsychiatric lupus (NPSLE) is a common disease manifestation in lupus patients; however, the underlying mechanisms are not fully understood. TWEAK is a cytokine member…
  • Abstract Number: 905 • 2015 ACR/ARHP Annual Meeting

    Citrullinated Epithelial-Derived Neutrophil-Activating Peptide 78 (ENA-78/CXCL5) Induces Monocyte Migration Via JNK and NFκB Signaling Pathways

    Ray A. Ohara1, Nicholas Lepore2, W. Alexander Stinson3, Gautam Edhayan3, Phillip L. Campbell1, Sarah Arwani1, Rachel Morgan1, Jeffrey H. Ruth1, Alisa E. Koch1,4, David A. Fox1 and M. Asif Amin1, 1Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 2University of Michigan, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 3Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 4Eli Lilly and Company, Indianapolis, IN

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by monocyte (MN) infiltration into the synovium. Citrullination is a post-translational modification of arginine to…
  • Abstract Number: 906 • 2015 ACR/ARHP Annual Meeting

    Distinct Expression of IL-36α, β, γ and Their Antagonists IL-36Ra and IL-38 in Psoriasis, Rheumatoid Arthritis and Crohn’s Disease

    Marie-Astrid Boutet1, Géraldine Bart2, Jérôme Amiaud1, Bénédicte Brulin3, Céline Charrier3, Franck Morel4, Jean-Claude Lecron4, Malvyne Rolli-Derkinderen5, Arnaud Boureille6, Cem Gabay7, Gaby Palmer8, Benoit Le Goff2 and Frédéric Blanchard9, 1Laboratoire de physiologie de la résorption osseuse, Inserm UMR 957, Nantes, France, 2Rheumatology, Nantes University Hospital, Nantes, France, 3Inserm UMR 957, Nantes, France, 4EA 4331, Poitiers, France, 5Inserm UMR 913, Nantes, France, 6Hepato-Gastroenterology Unit, Nantes University Hospital, Nantes, France, 7Rheumatology, Geneva University Hospital, Geneva, Switzerland, 8Geneva University Hospital, Geneva, Switzerland, 9Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Inserm UMR 957, Nantes, France

    Background/Purpose: The IL-36 family of cytokines comprises three agonists, IL-36α, IL-36β and IL-36g, an antagonist IL-36Ra, as well as IL-38, another potential IL-36 inhibitor. IL-36…
  • Abstract Number: 907 • 2015 ACR/ARHP Annual Meeting

    The Natural History of an Inception Cohort of Patients with Inflammatory Polyarthritis Followed for 20 Years: Disease Activity, Disability and Surgery

    James Gwinnutt1, Deborah P.M. Symmons1, Alex J Macgregor2, Jacqueline Chipping2, Tarnya Marshall2 and Suzanne M. Verstappen1, 1ARC Epidemiology, Stopford Building, ARC Epidemiology Unit, the University of Manchester, Manchester, United Kingdom, 2Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom

    Background/Purpose: There is little data on the 20 year outcome of patients with inflammatory polyarthritis (IP). Hence the aim of this study was to describe…
  • Abstract Number: 909 • 2015 ACR/ARHP Annual Meeting

    Smoking Behavior Changes after Rheumatoid Arthritis Diagnosis and Risk of Mortality during 36 Years of Prospective Follow-up

    Jeffrey A. Sparks1, Uyen Sa D.T. Nguyen2,3, Shun-Chiao Chang4,5, Yuqing Zhang6, Hyon Choi7 and Elizabeth W. Karlson4, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Clinical Epidemiology Research &Training Unit, Boston University School of Medicine, Boston, MA, 3Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 5Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 7Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Smoking is a major preventable cause of death and cessation is recommended for the general population. However, it is unclear whether being diagnosis with…
  • « Previous Page
  • 1
  • …
  • 1747
  • 1748
  • 1749
  • 1750
  • 1751
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology